Pharmazell (India) Private Limited, (Unit-I) – Chennai” Proposed Expansion of Basic Organic Chemicals (BOC) Manufacturing Facility and Product Quantity
Total Page:16
File Type:pdf, Size:1020Kb
Pre-Feasibility Report Pharmazell (India) Private Ltd., PRE FEASIBILITY REPORT For “Pharmazell (India) Private Limited, (Unit-I) – Chennai” Proposed Expansion of Basic Organic Chemicals (BOC) Manufacturing facility and Product Quantity At S. No. 164/1, Plot No. B5 & B6, MEPZ, Kadaperi Village, Tambaram Taluk, Kancheepuram District, Tamil Nadu December 2016 Eco Services India Pvt. Ltd., Chennai – 600032 Page _ Pre-Feasibility Report Pharmazell (India) Private Ltd., CHAPTER–1 EXECUTIVE SUMMARY Executive S.No. Description Summary 1. Identification of Pharmazell (India) Private Ltd, (Unit – I). was incorporated in the Project year 1993 in the name of “Diamalt Pharmorganica Private Limited” & established the factory in the year 1994. Trial production was started in the year 1995. The company is located at Madras Export Processing Zone (MEPZ), Tambaram, and Chennai- 600045. The plant mainly produces L-Cysteine Hydrochloride monohydrate, L-Cysteine Hydrochloride anhydrous and S-Carboxy methyl cysteine (carbocisteine) which finds application in pharmaceutical food processing and food preservation. Pharmazell (India) Private Ltd., proposed to expand its manufacturing facility and product quantity located at S.No. 164/1, Plot No. B5 & B6, MEPZ, Kadaperi Village, Tambaram Taluk, Kacheepuram District, Chennai The proposed project is categorized as „B‟ of 5(f) (as per the Gazette Notification dated 14th September, 2006. 2. Project M/s. Pharmazell (India) Private Ltd, (Unit – I), Chennai. Proponent 3. Brief Description The current report deals with increase in expansion of product quantity of Project from 1819.2 TPA to 2119.2 TPA (Carbocysteine product quantity increased from 300 TPA to 600 TPA) at MEPZ, Kadaperi Village, Tambaram, Chennai, Kancheepuram district in the state of Tamil Nadu. The Carbocisteine product is a muculative agent which is used for cough syrup manufacturing. Salient features 4. Total plot area 2.587 Acres (10,470 Sqm) 5. Product Quantity 2119.2 TPA 6. Location Particulars Details Latitude 12°56'51.87" N Longitude 80°07‟14.48" E Total Plot Area 10,470 Sq.m (2.587 Acres) Land Use Category Industrial Use Zone NH 48 – Chennai to Trichy Highway Nearest Highway (GST Road) Eco Services India Pvt. Ltd., Chennai – 600032 Page _ Pre-Feasibility Report Pharmazell (India) Private Ltd., Nearest Railway Station Tambaram (2 km) Chennai International Airport Nearest Airport (5.5 km) Nearest Harbour Chennai Port (25 km) 7. Project Cost 57.49 Crores (Existing: 54.49 Crores + Proposed : 3Crores) 8. Water For Existing Requirement Total Fresh water requirement : 228 KLD For Industrial use : 213 KLD For Domestic use : 15 KLD Proposed: Total Fresh water requirement : 332 KLD For Industrial use : 313 KLD For Domestic use : 17 KLD For Green Belt Requirement : 2 KLD (STP Treated water from MEPZ) Sewage & Effluent Generation: Existing: Domestic Sewage : 2 KLD Effluent generated from the plant : 110 KLD Low TDS Stream : 100 KLD I. Cooling Tower bleed off = 17 KLD II. Process & washing Waste water = 35 KLD III. Raw water RO Reject = 48 KLD High TDS stream : 10 KLD I. Softener regeneration = 2.5 KLD II. DM plant regeneration = 2 KLD III. Boiler Blow down = 3 KLD, IV. Scrubber bleed off = 2.5 KLD Proposed: Domestic Sewage : 2 KLD Effluent generated from the plant : 159 KLD Low TDS Stream : 145 KLD I. Cooling Tower bleed off = 20 KLD II. Process & washing Waste water = 80 KLD III. Raw water RO Reject = 45 KLD High TDS stream : 14 KLD I. Softener regeneration = 4 KLD II. DM plant regeneration = 4 KLD Eco Services India Pvt. Ltd., Chennai – 600032 Page _ Pre-Feasibility Report Pharmazell (India) Private Ltd., III. Boiler Blow down = 4 KLD IV. Scrubber bleed off = 2 KLD Details of Recycled & Recovered water: Exiting: Recycled water from ZLD : 80 KLD (Used for cooling tower make up) Recovered pure steam condensate : 10 KLD (Used for boiler feed) Proposed: Recycled water from ZLD : 100 KLD (Used for cooling tower make up) Recovered pure steam condensate : 20 KLD (Used for boiler feed) 9. Source MEPZ 10. Power Supply The power requirement for the proposed project is 2000 kVA and it is sourced from the nearby TNEB grid which is distributed through the substation within project premises. 2 Nos. of 750 kVA DG set has been installed at the plant as back-up power supply source for the plant. 11. Alternative Site No alternative site has been considered and the existing plant is situated inside the MEPZ. 12. Quantity of Existing: waste Bio Degradable waste : 10 Kg/day Nonhazardous waste (Packing materials, Used Insulation waste, Metal scrap) : 16 Kg/day Industrial hazardous waste : 0.418 Tons/day Proposed: Bio Degradable waste : 21 Kg/day Nonhazardous waste (Packing materials, Used Insulation waste, Metal scrap, Domestic recyclable) : 40 Kg/day Industrial hazardous waste : 0.59 Tons/day 13. Total waste The waste water generated from the plant would be 145 KLD. water generation The effluent generated from the plant will be segregated as HTDS, LTDS and utility streams and treated in the “Existing Waste water recycling plant (ZLD)”. 120 KLD of Treated water is recycled for cooling tower make up and Boiler feed. 14. Land use & land The plant is located within the Madras Export Processing Zone Ownership (MEPZ) and land use is Industrial Use Zone as per Chennai Metropolitan Development Authority (CMDA). Pharmazell (India) Private Ltd., (Unit-I) has the ownership over the Eco Services India Pvt. Ltd., Chennai – 600032 Page _ Pre-Feasibility Report Pharmazell (India) Private Ltd., total land area of 2.587 Acres (10,470 Sq.m) for Pharma development. 15. Conclusion Pharmazell (India) Private Ltd., (Unit-I) – Chennai, proposes to expand its Basic Organic Chemicals (BOC) manufacturing facility in order to provide affordable medicines to all. BOC manufacturing facility not only increases the market availability of organic chemicals but also reduces the import burden on the country and also support the government by paying the taxes will contribute the growth of Indian economy and strengthen the socio-economic values in the area. The proposed expansion project will adopt the state of the art technologies and a dedicated team of environmental professionals for treatment and recycling of effluents, operation and monitoring of all pollution control equipment. Pharmazell has a defined EHS policy and a robust Environmental Management system supported by a well-defined organizational structure to ensure the prevention of pollution and to protect the environment. Eco Services India Pvt. Ltd., Chennai – 600032 Page _ Pre-Feasibility Report Pharmazell (India) Private Ltd., CHAPTER - 2 INTRODUCTION OF THE PROJECT 2.0 IDENTIFICATION OF PROJECT AND PROJECT PROPONENT Pharmazell (India) Private Ltd. was incorporated in the year 1993 in the name of “Diamalt Pharmorganica Private Limited” & established the factory in the year 1994. Trial production was started in the year 1995. The company is located at Madras Export Processing Zone (MEPZ), Kadaperi Village, Tambaram Taluk, Kacheepuram District, Chennai in the State of Tamil Nadu - 600045. The company name was changed from “Diamalt Pharmorganica Private Limited” to “Bfgoodrich Diamalt Private Limited” in the year 1998. Again company name was changed from “Bfgoodrich Diamalt Private Limited” to Noveon Diamalt Private Limited” in the year 2001. Pharmazell acquired part of “NOVEON” and hence the company name was changed to “Pharmazell (India) Private Limited” in the year 2006. The plant mainly produces L-Cysteine Hydrochloride monohydrate, L-Cysteine Hydrochloride anhydrous and S-Carboxy methyl cysteine (carbocisteine) which finds application in pharmaceutical food processing and food preservation, Mucolytic. “Pharmazell (India) Private Limited” got its first CTO order (No.16426 dt.27.2.1998 for Water & No.12551 dt. 27.2.1998 for Air) from TNPCB in the name of Diamalt Pharmorganica Pvt. Ltd., with validity up to 31.03.1999. The company got enhancements in the year of 2008 vide the CTO order No. 21627 for Water Act and No. 17664 for Air Act dt.29.8.2008 with validity up to 31.03.2009. Recently the company got enhancements TNPCB vide Order No. 160814840869 for Water Act and CTO Order No. 160824840869 for Air Act dated 13.07.2016 with validity up to 31.03.2017. The present study is the proposed expansion of Basic Organic Chemicals (BOC) with the production quantity of 1819.2 TPA to 2119.2 TPA (Carbocysteine product quantity increased from 300 TPA to 600 TPA in the land extent of 2.587 Acres Acres at S.No. 164/1, Plot No. B5 & B6, MEPZ, Kadaperi Village, Tambaram Taluk, Kacheepuram District, Chennai Pharmazell (India) Private Limited is one of the leading Pharmaceutical companies in India, engaged in the development, manufacturing and distribution of Organic Chemical. Pharmazell (India) Private Limited currently consists of more than 150 employees, consistently ranked among fastest growing pharmaceutical companies in India. Eco Services India Pvt. Ltd., Chennai – 600032 Page _ Pre-Feasibility Report Pharmazell (India) Private Ltd., 2.1 BRIEF DESCRIPTION OF THE NATURE OF PROJECT Pharmazell (India) Private Limited is one of the leading Pharmaceutical companies in India, engaged in the development, manufacturing and distribution of Basic Organic Chemicals (BOC) at S.No. 164/1, Plot No. B5 & B6, MEPZ, Kadaperi Village, Tambaram Taluk, Kacheepuram District, Chennai in the year of 1994. The company proposes to expand its Basic Organic Chemicals (BOC) manufacturing capacity in the existing premises with a total investment of Rs. 57.49 Crores including the existing investment of Rs 54.49 Crores (GFA certificate Attached as Annexure-IV). The project site lies between 12°56'51.87" North latitude and 80°07‟14.48" East longitude. The project site is well connected by the National and State High Ways. 2.2 Company Profile A Thorough Understanding of Our Clients Needs: PharmaZell develops and produces pharmaceutical active ingredients (API), provides services for formulation development and compiles required regulatory documents/dosiers for both the originator and generic pharmaceutical industry.